The LSU Health New Orleans School of Medicine has enrolled its first patient in a randomized clinical trial to evaluate the safety and effectiveness of hydroxychloroquine alone, and in combination, as a treatment for COVID-19. “We may enroll up to 600 ...
from Google Alert - health https://ift.tt/2wXsPaO
via IFTTT
0 comments:
Post a Comment